Key Takeaways
- The VIA360™ Surgical System immediately after cataract surgery resulted in reduced intraocular pressure and medication usage in patients with glaucoma.
- After a median follow-up of 38.5 days, mean IOP was reduced from a mean of 17.1 mmHg at baseline to 12.8 mmHg by last follow-up.
- Adverse events were reportedly mild; no eyes lost 2 lines or more of vision.
A retrospective study of real-world patients showed that use of the VIA360™ Surgical System immediately after cataract surgery resulted in reduced intraocular pressure (IOP) and medication usage in patients with glaucoma.
Between April and September 2025, 18 eyes from 12 patients (mean age, 73.5 years) at the University of Colorado were assessed for outcomes. All canaloplasties were performed immediately after cataract surgery. Most patients (61.1%) had primary open-angle glaucoma, and severity was mild in most cases (83.3%). Half had received prior laser iridotomy or trabeculoplasty.
Over 180 degrees of viscodilation was achieved in 94.4% of patients (n=17 eyes). After a median follow-up of 38.5 days, mean IOP was reduced from a mean of 17.1 mmHg at baseline to 12.8 mmHg by last follow-up (P=0.002), and medications were reduced from 1.3 to 0.4 (P<0.001). At last follow-up, 55.5% of eyes were not receiving any medication.
Adverse events were reportedly mild; no eyes lost 2 lines or more of vision. Two eyes (11.1%) experienced rebound iritis, and cystoid macular edema occurred in 1 eye (5.5%). No other complications were reported.
The study is limited by its short follow-up and small patient population.
Reference
Tan N, Spitz M, Assi L, et al. Early real-world outcomes of VIA360 canaloplasty combined with phacoemulsification. Poster presented at: American Glaucoma Society Annual Meeting; February 19-22, 2026; Rancho Mirage, CA.
Related Content
